OrthoPediatrics ( KIDS ) Q2 Revenue Up 16%
OrthoPediatrics ( NASDAQ:KIDS ) , a specialist in pediatric orthopedic medical devices, reported its financial results for the second quarter on August 5, 2025. OrthoPediatrics reported GAAP revenue of $61.1 million in the second quarter but slightly below Wall Street's $61.47 million GAAP ...
OrthoPediatrics ( KIDS ) Reports Q2 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +35.29% and -1.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics - OrthoPediatrics ( NASDAQ:KIDS )
WARSAW, Ind., Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) KIDS, a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ( "OPSB" ) division with ...
OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
WARSAW, Ind., Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case of the new 3P™ Pediatric Plating ...
OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case - OrthoPediatrics ( NASDAQ:KIDS )
WARSAW, Ind., Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) KIDS, a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case of the new 3P™ Pediatric Plating Platform™ Hip ...
Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products
WARSAW, Ind., July 16, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced a significant milestone in the ongoing Global POISE ( Pediatric ...
OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
Reinforced Long-Term Commitment as Emerald Sponsor Reinforced Long-Term Commitment as Emerald Sponsor ...
OrthoPediatrics ( KIDS ) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -50% and 1.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System - OrthoPediatrics ( NASDAQ:KIDS )
WARSAW, Ind., May 07, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) KIDS, a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating ...
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System - OrthoPediatrics ( NASDAQ:KIDS )
WARSAW, Ind., April 08, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) KIDS, a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat ...
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
WARSAW, Ind., April 08, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, ...
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 25, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, ...
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
WARSAW, Ind., March 24, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana.
OrthoPediatrics ( KIDS ) Reports Q4 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -31.82% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
RxSight, Inc. ( RXST ) Misses Q4 Earnings Estimates
RxSight (RXST) delivered earnings and revenue surprises of -70% and 0.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Globus Medical ( GMED ) Q4 Earnings and Revenues Top Estimates
Globus Medical (GMED) delivered earnings and revenue surprises of 10.53% and 2.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
WARSAW, Ind., Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full ...
Nevro ( NVRO ) Soars 13.9%: Is Further Upside Left in the Stock?
Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
WARSAW, Ind., Jan. 22, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing ...
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division - OrthoPediatrics ( NASDAQ:KIDS )
WARSAW, Ind., Jan. 10, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) KIDS, a company focused exclusively on advancing the field of pediatric orthopedics, today announced the rapid expansion of its Specialty Bracing ( OPSB ) division with entrance into 3 ...
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
WARSAW, Ind., Jan. 10, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced the rapid expansion of its Specialty Bracing ( OPSB ) division with ...
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
WARSAW, Ind., Dec. 05, 2024 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics today announced that the OrthoPediatrics Specialty Bracing ( OPSB™ ) division is ...
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products - OrthoPediatrics ( NASDAQ:KIDS )
WARSAW, Ind., Dec. 05, 2024 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) KIDS, a company focused exclusively on advancing the field of pediatric orthopedics today announced that the OrthoPediatrics Specialty Bracing ( OPSB™ ) division is expanding its ...
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace - OrthoPediatrics ( NASDAQ:KIDS )
WARSAW, Ind., Nov. 26, 2024 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) KIDS, a company dedicated exclusively to advancing the field of pediatric orthopedics, is excited to announce significant updates to the DF2® Brace, a cornerstone product within the ...
OrthoPediatrics ( KIDS ) Reports Q3 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -50% and 1.21%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
What Makes OrthoPediatrics ( KIDS ) a New Strong Buy Stock
OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BRKR Stock Might Gain From the Newly Launched OptoVolt Module
At the Neuroscience 2024 conference, Bruker released its latest OptoVolt module, which seamlessly integrates with Ultima 2Pplus microscope and NeuraLight 3D SLM.
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors - Axogen ( NASDAQ:AXGN ) , Bruker ( NASDAQ:BRKR )
Bruker Corporation BRKR recently announced the acquisition of Dynamic Biosensors GmbH, or DBS, a pioneering company known for its development in biosensors. The acquisition is aimed at boosting Bruker's biophysical portfolio, which is used for analyzing molecular interactions and kinetics.
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors
BRKR acquires Dynamic Biosensors or DBS. DBS's unique products, along with BRKR's SPR portfolio, should help the latter establish a leading biosensors business.
New Animal Health Products, Vaccine Sales Support PAHC Stock
Phibro Animal Health is focusing on new developments, incremental registrations and volumes of existing vaccine technologies.
Down -15.65% in 4 Weeks, Here's Why You Should You Buy the Dip in OrthoPediatrics ( KIDS )
OrthoPediatrics (KIDS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near ...
HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise?
Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO.
QIAGEN Launches QIAcuityDx Digital PCR System: Stock to Gain?
QGEN expands its digital PCR portfolio with the newly launched QIAcuityDx Digital PCR System. The system will be used for clinical testing in oncology across North America and Europe.
BSX Stock Gains From FARAPULSE PFA's PMDA Approval in Japan
Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in the country in the upcoming weeks.
HOLX Stock Gains From New Offerings Despite Macro Issues - Axogen ( NASDAQ:AXGN ) , Hologic ( NASDAQ:HOLX )
Hologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, macroeconomic issues and unfavorable FX headwinds continue to impede growth. The stock carries a Zacks Rank #3 ( Hold ) currently.
HOLX Stock Gains From New Offerings Despite Macro Issues
In Breast Health, Hologic expands its product offering from imaging to cover the continuum of breast cancer care, including biopsy and surgery.
VRNOF Stock Likely to Gain From Its Newly Opened Dispensary in Phoenix
Verano is set to open a new Zen Leaf Arcadia in Phoenix, AZ, today. Zen Leaf Arcadia is located at 2710 E Indian School Road, Phoenix. It will be open daily from 8 a.m. to 10 p.m. local time.
Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock
Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours.
QIAGEN Stock Likely to Gain From PreAnalytiX's Newly Launched PAXgene
PreAnalytiX, a joint venture of QGEN and BD, introduces the PAXgene Urine Liquid Biopsy Set. QGEN will commercialize the latest set.
Inspira Stock to Gain From its Appearance at Annual ELSO Conference
At the 34th annual ELSO conference in Detroit, IINN will present its FDA-cleared latest and future technology, the INSPIRA ART100 system.
Bears are Losing Control Over OrthoPediatrics ( KIDS ) , Here's Why It's a 'Buy' Now
OrthoPediatrics (KIDS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a ...
STIM Stock Likely to Gain From Updated TMS Coverage
Neuronetics announces that TMS coverage has been updated to reduce access barriers for patients with MDD. In line with this, BCBS and Louisiana Medicaid have expanded their TMS coverage.
TNDM Stock Likely to Gain From Innovation Amid Competition
Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for people living with the condition.
EDAP's Avenda Deal for AI-Assisted Cancer Care Likely to Drive Stock
When combined with EDAP's Focal One platform, Avenda's Unfold AI enables more accurate and patient-specific treatment options.
BiomX Stock Gains From Favorable Study Data Presentation on BX004
PHGE is set to present data from its Phase 1b/2a study for BX004 at the North American Cystic Fibrosis Conference in Boston on Sept. 27 and Sept. 28.
VERO Stock Likely to Get Support From New Regulatory Nod in Australia
The latest approval for Venus Concept in Australia reinforces its position as a global player in the aesthetic technology space.
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the United States.
QGEN Stock Likely to Gain From Newly Launched Assays for QIAcuity
QIAGEN launches 100 new assays for QIAcuity. The newly launched assays are now available through the company???s GeneGlobe platform.
BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain?
Boston Scientific received FDA approval on the expanded indication for INGEVITY+ Pacing Leads. Data demonstrated this lead to be safe and effective for LBBA pacing.
Does OrthoPediatrics ( KIDS ) Have the Potential to Rally 36.3% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 36.3% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
